Celldex Therapeutics, Inc. is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

View all →   RSSRecent Releases
Jul 11, 2016 Celldex Therapeutics Initiates Phase 1/2 Clinical Trial of New Product Candidate CDX-014 in Advanced Renal Cell Carcinoma
Jul 7, 2016 Celldex Therapeutics to Participate in the Cantor Fitzgerald 2nd Annual Healthcare Conference
More →Upcoming Events
Details on upcoming events are not yet available.
Featured Financial Reports
Filing Date Title Type Size
May 5, 2016 Form 10-Q View HTML View PDF 312.7 KB Add to Briefcase
Feb 25, 2016 Form 10-K/A View HTML View PDF 1.1 MB Add to Briefcase
Add to Briefcase = add file to Briefcase